Ministers take note: now is the moment to fight to keep AstraZeneca’s listing in London | Nils Pratley
AstraZeneca's CEO, Pascal Soriot, recently hinted at the possibility of moving the company's stock market listing from London to the US during its half-year results. While he didn’t outright confirm the move, his comments were enough to raise eyebrows in Westminster. The article urges UK ministers to act quickly to keep the pharmaceutical giant’s listing in London, emphasizing the importance of retaining such a flagship British company.
WPN Brief
AstraZeneca's CEO, Pascal Soriot, recently hinted at the possibility of moving the company's stock market listing from London to the US during its half-year results. While he didn’t outright confirm the move, his comments were enough to raise eyebrows in Westminster. The article urges UK ministers to act quickly to keep the pharmaceutical giant’s listing in London, emphasizing the importance of retaining such a flagship British company.
Ask WPN AI